- Home
- ACTU vs BANX Comparison
ACTU vs BANX Comparison
Compare ACTU & BANX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACTU
- BANX
- Stock Information
- Founded
- ACTU 2015
- BANX 2013
- Country
- ACTU United States
- BANX United States
- Employees
- ACTU N/A
- BANX N/A
- Industry
- ACTU
- BANX Trusts Except Educational Religious and Charitable
- Sector
- ACTU
- BANX Finance
- Exchange
- ACTU NYSE
- BANX Nasdaq
- Market Cap
- ACTU 135.0M
- BANX 149.0M
- IPO Year
- ACTU 2024
- BANX N/A
- Fundamental
- Price
- ACTU $8.00
- BANX $20.24
- Analyst Decision
- ACTU Strong Buy
- BANX
- Analyst Count
- ACTU 1
- BANX 0
- Target Price
- ACTU $20.00
- BANX N/A
- AVG Volume (30 Days)
- ACTU 42.0K
- BANX 25.8K
- Earning Date
- ACTU 05-21-2025
- BANX 06-13-2025
- Dividend Yield
- ACTU N/A
- BANX 10.45%
- EPS Growth
- ACTU N/A
- BANX N/A
- EPS
- ACTU N/A
- BANX 2.35
- Revenue
- ACTU N/A
- BANX $29,467,794.00
- Revenue This Year
- ACTU N/A
- BANX N/A
- Revenue Next Year
- ACTU N/A
- BANX N/A
- P/E Ratio
- ACTU N/A
- BANX $8.61
- Revenue Growth
- ACTU N/A
- BANX 2.73
- 52 Week Low
- ACTU $5.51
- BANX $17.91
- 52 Week High
- ACTU $11.73
- BANX $21.67
- Technical
- Relative Strength Index (RSI)
- ACTU N/A
- BANX 51.50
- Support Level
- ACTU N/A
- BANX $18.37
- Resistance Level
- ACTU N/A
- BANX $19.24
- Average True Range (ATR)
- ACTU 0.00
- BANX 0.67
- MACD
- ACTU 0.00
- BANX 0.06
- Stochastic Oscillator
- ACTU 0.00
- BANX 71.66
About ACTU ACTUATE THERAPEUTICS INC
Actuate Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing therapies for the treatment of high impact, difficult to treat cancers through the inhibition of glycogen synthase kinase-3 (GSK-3). It is developing elraglusib (formerly 9-ING-41), a small molecule that is designed to enter cancer cells and block the function of the enzyme GSK-3B, a master regulator of complex biological signaling cascades, including those mediated by oncogenes, that lead to tumor cell survival, growth, migration, and invasion.
About BANX ArrowMark Financial Corp.
ArrowMark Financial Corp is a non-diversified, closed-end management investment company. Its objective is to provide stockholders with current income, and to a lesser extent capital appreciation. The company's investments in various portfolios such as debt securities, Trust Preferred and Preferred Securities, preferred securities, exchange-traded funds, money market funds, and others.